Effectiveness of Venetoclax Plus Decitabine Conditioning Regimen for Allogeneic HSCT in High-Risk Myeloid Neoplasms Patients


Advertisement

Effectiveness of Venetoclax Plus Decitabine Conditioning Regimen for Allogeneic HSCT in High-Risk Myeloid Neoplasms Patients

Oct 27, 2023

ABOUT THE CONTRIBUTORS

MORE ARTICLES BELOW

PW Weekly Newsletters

The latest articles and insights from your colleagues in your specialty(ies) of choice.